These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Review of topical beta blockers as treatment for infantile hemangiomas. Painter SL; Hildebrand GD Surv Ophthalmol; 2016; 61(1):51-8. PubMed ID: 26408055 [TBL] [Abstract][Full Text] [Related]
4. Local administration of β-blockers for infantile hemangiomas: a systematic review and meta-analysis. Ovadia SA; Landy DC; Cohen ER; Yang EY; Thaller SR Ann Plast Surg; 2015 Feb; 74(2):256-62. PubMed ID: 25590249 [TBL] [Abstract][Full Text] [Related]
5. Assessment of the effectiveness of topical propranolol 4% gel for infantile hemangiomas. Mashiah J; Kutz A; Rabia SH; Ilan EB; Goldberg I; Sprecher E; Harel A Int J Dermatol; 2017 Feb; 56(2):148-153. PubMed ID: 28074521 [TBL] [Abstract][Full Text] [Related]
6. Outpatient use of oral propranolol and topical timolol for infantile hemangiomas: survey results and comparison with propranolol consensus statement guidelines. Kumar MG; Coughlin C; Bayliss SJ Pediatr Dermatol; 2015; 32(2):171-9. PubMed ID: 25556828 [TBL] [Abstract][Full Text] [Related]
7. Efficacy and Safety of Topical Timolol for the Treatment of Infantile Hemangioma in the Early Proliferative Stage: A Randomized Clinical Trial. Muñoz-Garza FZ; Ríos M; Roé-Crespo E; Bernabeu-Wittel J; Montserrat-García MT; Puig L; Gich I; Baselga E JAMA Dermatol; 2021 May; 157(5):583-587. PubMed ID: 33825828 [TBL] [Abstract][Full Text] [Related]
8. Recurrence of infantile hemangioma after termination of propranolol treatment. Chang L; Ma G; Jin Y; Ye X; Qiu Y; Chen H; Yu W; Yang X; Hu X; Lin X Ann Plast Surg; 2014 Feb; 72(2):173-5. PubMed ID: 24406852 [TBL] [Abstract][Full Text] [Related]
9. Effect of topical propranolol gel on plasma renin, angiotensin II and vascular endothelial growth factor in superficial infantile hemangiomas. Tang YJ; Zhang ZZ; Chen SQ; Chen SM; Li CJ; Chen JW; Yuan B; Xia Y; Wang L J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):759-762. PubMed ID: 26489635 [TBL] [Abstract][Full Text] [Related]
10. β-blockers in the treatment of periocular infantile hemangioma. Al-Haddad C; El Salloukh NA; El Moussawi Z Curr Opin Ophthalmol; 2019 Sep; 30(5):319-325. PubMed ID: 31394556 [TBL] [Abstract][Full Text] [Related]
11. Topical Timolol Maleate 0.5% for Infantile Hemangioma: Its Effectiveness Compared to Ultrapotent Topical Corticosteroids - A Single-Center Experience of 278 Cases. Danarti R; Ariwibowo L; Radiono S; Budiyanto A Dermatology; 2016; 232(5):566-571. PubMed ID: 27592104 [TBL] [Abstract][Full Text] [Related]
12. Treatment of problematic infantile hemangiomas with propranolol: a series of 40 cases and review of the literature. Oksiuta M; Matuszczak E; Dębek W; Dzienis-Koronkiewicz E; Hermanowicz A; Tylicka M Postepy Hig Med Dosw (Online); 2014 Sep; 68():1138-44. PubMed ID: 25228522 [TBL] [Abstract][Full Text] [Related]
13. Is Routine Electrocardiography Necessary Before Initiation of Propranolol for Treatment of Infantile Hemangiomas? Yarbrough KB; Tollefson MM; Krol AL; Leitenberger SL; Mann JA; MacArthur CJ Pediatr Dermatol; 2016 Nov; 33(6):615-620. PubMed ID: 27599450 [TBL] [Abstract][Full Text] [Related]
14. [Chinese expert consensus on the use of topical timolol maleate treatment of infantile hemangiomas]. Zheng JW; Wang XK; Jiang CH; Qin ZP; Fan XD; Yang YW; Huo R; Liu SH; Zhao JH; Wang XY; Zhou DK; Lei SR Shanghai Kou Qiang Yi Xue; 2016 Dec; 25(6):744-747. PubMed ID: 28275803 [TBL] [Abstract][Full Text] [Related]